chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My daughter received the second dose of the Pfizer COVID-19 vaccine on 12/10/2021. On 12/20/2021, my daughter began to experience coughing, pain in both legs, fatigue, sore throat, and sneezing. I put VICKS VAPORUB on the bottoms of her feet, put socks on her, bundled her up, and put her to bed. She said that she felt a little better, but she was still tired. Her coughing and sneezing continued, and I fed her soup. At this point, I thought that she just had allergies, and COVID-19 didn't cross my mind. She slept a lot. On 12/25/2021, she went to visit her aunt and grandmother and spent the night at their place. When I picked her up on 12/26/2021, she had a fever, coughing, sneezing, and fatigue. She didn't have an appetite. When we got home, I gave her a room temperature bath and DIMETAPP, TYLENOL, and VICKS VAPORUB. Her temperature was 101 and it stayed between 101 and 103. I bundled her up and took her to bed. When it reached 104, I called her doctor and then took her to an urgent care. On 12/28/2021, she underwent a PCR test, which yielded a positive result. She had no appetite, so she lost 10 lbs. I gave her soup, alkaline water, PEDIALYTE, oxygen water, bread, and bananas. I gave her MUCINEX DM, DIMETAPP, TYLENOL, and a lot of vitamin C. She was prescribed an albuterol inhaler, which she had to use 2-3 times a day. On the night of 12/26/2022, she threw up and had diarrhea. She had severe night sweats, sore throat, loss of voice, a very runny nose, and a severe headache. The TYLENOL helped break her fever and take care of some of the pain. She also had a strong cough that sometimes made her lose control of her bladder. She finally began to get better about 1/3/2022. Her fever and sore throat were gone. She regained her appetite and was able to eat solid foods again and craved her favorite foods. The runny nose was gone. She still had a cough, but it was much less frequent. On 1/6/2022, a rapid test was conducted, and she got a negative result. We were able to go out for walks and get sunshine and fresh air at this point. She was also able to participate in her home school activities with no problem. When I went back to work about a month later, she was fine with going back to her day care center. It has been nearly a year since these events happened, but my daughter is still apprehensive about going to public places besides the day care center. When we are in public, she tends to be very clingy towards me. She is afraid of getting COVID-19 again, and she's also afraid of my possibly getting it, because she is frightened by the possibility of my dying. We have lost 12 or 13 family members and friends to the pandemic. Not only is she traumatized by having had the virus herself, but she also been traumatized from having lost so many people in short span of time.
One week after receiving the second dose of the Moderna Covid-19 Vaccine, the patient had some swelling and itching at the injection site. The second dose was received on 3/9/2021, and the reaction began on 3/14/2021. The patient reported the event to the pharmacy on 3/18/2021. This reaction is known as "Covid arm". She has tried aloe cream as well as cortisone cream during the day. The patient has taken Tylenol PM (acetaminophen and diphenhydramine) at night.
whole upper arm hurting (only at injection site 1st dose); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Mar2021 (Batch/Lot number: unknown) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "colitis" (not ongoing), notes: not present now or has been for over a decade. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "whole upper arm hurting (only at injection site 1st dose)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: The patient has no known allergies. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 (as reported).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unspecified date, the patient received an improperly stored dose of VARIVAX Lot # M036293 with an expiration date on 17-AUG-2018 for prophylaxis (strength and route of administration was not reported). The vaccine was stored at a temperature between 15°F to 46°F during 12 hours. No previous temperature excursions were reported and the call was not because of a data logger. Additionally, no adverse effects were reported.
Shortness of breath, used inhaler Leg pain/cramping Headache Extreme fatigue Heart palpitations Fever 101 Dizziness Nausea  Body aches and pains
first vaccine 8/5/21: pain/swelling at injection site, flu like symptoms, large joint pain, 103* F fever, extreme fatigue for 5 days s/p vaccine. pain in joint lingered until second vaccine 8/26/21: stated symptoms above, joint pain more severe after second vaccine. muscles and joint pain still present s/p 4mo after the vaccine.
p/ 7-10 days following 2nd dose of vax pt cried unconsolably for 15-20 mins; pt almost taken to ER however went to sleep later & sobbing cont; developmental delay followed gradually;
Received Tdap in left arm - deltoid - on 1/3/11.  Pain and swelling @ injection site x 2 days.  1/6/11:  onset of redness, swelling, increased warmth extending to elbow.  Temp 1/6/11:  98.7F.  1/6/11 seen @ Urgent Care.  MD treated client for allergic reaction to vaccine.  Started on Prednisone 10 mg (6 day tapered dose), OTC Benadryl, Tylenol PRN.  To return to PMD 1/12/11 if not improved. 1/10/11:  Phone call to client:  swelling resolved, slight redness remains; continues Prednisone as ordered.  Symptoms improving.
Stomach ache and severe fatigue lasting approx. 2 hours, daily for approx. 3 weeks, thereafter every few days for approx. 6 weeks.
She work up next morning with lips swelling & she said she noticed that the 2nd time also.  Told her to get some Benadryl to help with recovery since this is her 3rd shot & her 2nd shot she got the same symptoms.
Client lightheaded post vaccination, brief vasovagal syncope, lasting about 10 seconds. No fall or injuries, vitals stable, fully recovered in about 10 minutes time.
2 Hours after injection, patient was home and began feeling full body stiffness, pain, and swelling.  Reported to pharmacy roughly 36 hours later with visible inflammation/swelling in lower extremities.  No other medications/vaccinations had been completed in the same time frame.
This spontaneous prospective pregnancy report as received from a physician refers to a 16 year old female patient. No pertinent medical history or drug reactions/allergies were reported. On 23-NOV-2010 the patient was vaccinated with the first dose of GARDASIL (lot# not reported) 0.5 ml, intramuscular. The patient received her second dose of GARDASIL (lot#, dose and route not reported) on 30-JUL-2014. The physician stated that the patient also received a "hepatitis A vaccine" (manufacturer unknown). No concomitant medication was reported. She stated that the patient's urine was tested for HCG, and the patient was found to be pregnant after receiving the GARDASIL. The patient sought medical attention via office visit. The physician stated that the patient had not yet seen the OB/GYN and gestation had not yet been determined. No adverse effects reported. The Menstrual Period and Estimated date of delivery were not known. The outcome of the events was unknown. Additional information has been requested.
This spontaneous report as received from the patient's mother, refers to her female daughter of unknown age. The patient's medical history and concurrent conditions were not reported. The reporter stated that her daughter was vaccinated on unknown dates in 2003 and 2006, with doses of M-M-R II (Lot number for the vaccine received in 2003 was reported as: 1035N and for the one received in 2006: 1468F) (route of administration and expiration dates were not provided). No concomitant medications were reported. The patient's mother reported that on an unspecified date, after receiving vaccination, her daughter experienced unspecified issues. No more details were given about the adverse event. The outcomes of the unspecified issues were unknown. Additional information has been requested.
Swollen, inflamed, itchy, painful area about 4 inches surrounding injection site starting 48 hours after inoculation.
first dose: sore achy arm/ sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101863766 (Pfizer).  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Feb2021 (Lot number: EM9809) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "heart condition" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Augmentin for tooth infection, reaction(s): "anaphylaxis", notes: a negative reaction to a medicine is a couple years ago he developed an infection, a tooth infection maybe, he can't remember, and a doctor prescribed Augmentin, an antibiotic he has taken a number of times over the decades Augmentin, an antibiotic he has taken a number of times over the decades, but this one time, he almost went into anaphylaxis, he had finally caught his breath by the time; Augmentin for tooth infection, reaction(s): "finally caught his breath". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 06Feb2021, outcome "recovered" (07Feb2021), described as "first dose: sore achy arm/ sore arm". No follow-up attempts are possible. No further information is expected.
Extreme pain in arm for 72 hrs.  Continued pain for 2 more days.
3 days after vaccine --difucs throbbing pain back of head and down the back of the neck. Comes and goes. Tylenol does not help. Continues up to and including day of reporting.
April 2, 2021?-4 to 4 1/2 hours after dose...temperature started to rise?feeling clammy.  Chills set in ?took 1500mg of extra strength Tylenol.  In middle of night ?woke up 2-3 times with racing heart?could not get it to slow down on my own(breathing ,etc) eventually slowed down on its own. High fever at the time. At 5:00am took temperature for first time 102.0?took 600mg of ibuprofen.  Drinking lots of fluids.  Headache and back of neck pain continued to get worse at 11:30am took 1500 mg of extra strength Tylenol and crawled back in bed.  Woke up 3:45 burning up/chills took shower to cool body down?could tell temperature way to high?skin very hot to touch.  A little disoriented climbing into shower?had to hold the wall in shower to stand steady. Once out of shower?wife and son got home and concerned how I looked.  She took temperature at 4:15-4:30 pm and temperature read 107.8.?took 2 more times and both read 107.9 and 107.9...took 600mg of ibuprofen at 4:30 and went toHospital É.R. At 5:30 pm.
Pt recv vax; on 1/18/95 pt exp rapid weight loss to 95 lbs, muscle loss
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a adult female patient who received SHINGRIX (batch number 7X743, expiry date 22nd May 2021) for prophylaxis. On 20th October 2018, the patient received SHINGRIX (intramuscular). On 20th October 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema and injection site warmth. On 26th October 2018, the outcome of the injection site erythema and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX on left arm. The patient experienced injection site hot to touch. Limited information was provided by the pharmacist.
10 days p/vax noticed tenderness in rt arm pit & shoulder area;noticed tender swelling in arm pit;sought MD advise as a result of this;armpit cont to be tender;also tiredness;
Nurse did not believe my mother when told she already had both vaccinations (Pfizer-lot #EL5318-2/12/2021 and Pfizer-Lot#EN5318 3/5/2021.  Nurse had my mother sign authorization form.  She had immediate fatigue, weakness and exhaustion.  This continued and her overall health declined until she was admitted to Acute Care Facility on May 25, 2021.  She went from walking with a walker (50-60 feet with assistance) , to only walking 4 steps with max assistance.
Fever; Chills; Itchy neck outside; Itchy throat; Stiff shoulder; Pin and needles; joint pain in shoulder and arms; This is a spontaneous report from a contactable other healthcare professional (HCP, patient herself). A 25-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: EL1284, expiration date: unknown), intramuscularly on the right arm on 31Dec2020 at 15:30 at a single dose for COVID-19 immunization administered at the hospital. The patient's medical history and concomitant medications were not reported. The patient had no known allergies; no allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Dec2020 at 19:00, the patient experienced fever, chills, itchy neck outside, itchy throat, stiff shoulder, pin and needles, and joint pain in shoulder and arms. The reporter assessed the events as non-serious. The patient did not receive any treatment for the events. The patient was recovering from all the events.
on day 11 post vaccine, C/O left upper back pain over shoulder blade radiating down to lower side
Patient had reported not eating for the last few hours prior to administration. She was monitored for 15 minutes prior to exiting the OCC health clinic with no S/S of adverse reaction. She had reported feeling well just hungry. She was working in a factory in heated conditions at time the symptoms started 1 hour after administration. One hour after leaving the occupational health clinic patient started feeling anxious, all over numbness and tingling, SOB that resolved quickly, lightheaded, shaking, flushed, no hives, itching or other complaints. She was sent to the ER for further eval and treatment. Outcomes not available at this time.
body malaise; diarrhea; runny nose; sore throat; fever; dizziness; This is a spontaneous report from a non-contactable nurse. An adult female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1686 and expiry date: unknown), intramuscular on the left arm, on 20Jan2021 07:30 at a single dose for COVID-19 immunization. The first dose was received on 29Dec2020 07:30 (lot number: EL1284), intramuscular on the left arm. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. On 29Jan2021 11:00, the patient experienced body malaise, diarrhea, runny nose, sore throat, fever, dizziness for 3 days. Patient was recovering from the events and did not received treatment. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  No follow-up attempts are possible. No further information is expected.
episodes of high blood pressure; dizzy spell; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (episodes of high blood pressure), DIZZINESS (dizzy spell) and PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included GERD and Blood pressure high.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (episodes of high blood pressure) and DIZZINESS (dizzy spell). On 13-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 20-Apr-2021, DIZZINESS (dizzy spell) had resolved. At the time of the report, BLOOD PRESSURE INCREASED (episodes of high blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood pressure measurement: 108/62 108/62, 134/82 134/82., 144/80 144/80, 155/80 155/80 and 142/91 142/91.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment medication were not provided   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up(TCR) information received on 18-JUN-2021 contains non-significant information.
The 2nd shingles vaccine was given to my on 8/10/2020.   On 8/13/2020 I woke up in the morning and my right ear was dead.  I could not hear at of it at all. My doctor said to get in to see and ENT.  I called healthcare provider and went to her on 8/17/20.  She did a hearing test and looked in my ear and said she feels I have SSHL.  I did blood work and I have an MRI of the brain on 9/1/20.  The side effects that I was given did not include the rare effects that the CDC states can have pneumonia, hearing problems, blindness, brain inflamation or death.  I am scared to death I am going to have more effects.  Please get back to me about this asap.  My cell number.
looks like a freak; lips have blown up; outside around her eyes (face) are tender; head was in a vice grip; all of the common side effects; couldn't move her left arm; headache; shooting pain headaches; painful left arm; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (painful left arm), LIP SWELLING (lips have blown up), MOBILITY DECREASED (couldn't move her left arm), DEREALISATION (looks like a freak) and ASTHENIA (all of the common side effects) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Asthma. Concomitant products included LIOTHYRONINE SODIUM (CYTOMEL) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore left arm). On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (painful left arm). On 10-Feb-2021, the patient experienced MOBILITY DECREASED (couldn't move her left arm), HEADACHE (headache) and HEADACHE (shooting pain headaches). On 10-Feb-2021 at 10:00 PM, the patient experienced ASTHENIA (all of the common side effects) and HEAD DISCOMFORT (head was in a vice grip). On 11-Feb-2021, the patient experienced LIP SWELLING (lips have blown up) and EYE PAIN (outside around her eyes (face) are tender). On an unknown date, the patient experienced DEREALISATION (looks like a freak). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Fever, at a dose of 1 dosage form. On 16-Jan-2021, VACCINATION SITE PAIN (sore left arm) had resolved. On 11-Feb-2021, PAIN IN EXTREMITY (painful left arm) and MOBILITY DECREASED (couldn't move her left arm) had resolved. At the time of the report, LIP SWELLING (lips have blown up), DEREALISATION (looks like a freak), ASTHENIA (all of the common side effects), EYE PAIN (outside around her eyes (face) are tender), HEAD DISCOMFORT (head was in a vice grip), HEADACHE (headache) and HEADACHE (shooting pain headaches) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Non-significant Follow up Appended - Reporter mail address updated
Site reaction (large red area) one week after injection along with pain. Inflammation lasted 4 days then resolved on own.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "recurrent aphthous ulcers." (unspecified if ongoing), notes: None, other than recurrent aphthous, ulcers. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 including PAXLOVID given on 21Sep2022 to 24Sep2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.1 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162b2, BNT162b2 omi ba.4-5  vaccine in this patient cannot be completely excluded.
PATIENT FELT LIGHTHEADED BUT THINKS IT MAY BE ANXIETY RELATED. PATIENT HELD EXTRA 5 MINS THEN SYMPTOMS RESOLVED.